NovaBay Pharmaceuticals Inc (NBY.A)

NBY.A on American Stock Exchange

0.77USD
21 Oct 2014
Price Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.77
Open
$0.77
Day's High
$0.77
Day's Low
$0.75
Volume
13,190
Avg. Vol
53,158
52-wk High
$1.85
52-wk Low
$0.69

NBY.A

Chart for NBY.A

About

NovaBay Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on addressing the unmet therapeutic needs of the global anti-infective market. The Company’s Aganocide compounds, led by NVC-422, are patented, synthetic molecules with a spectrum of activity against bacteria, viruses and fungi. The Company is... (more)

Overall

Beta: 0.56
Market Cap (Mil.): $38.98
Shares Outstanding (Mil.): 50.78
Dividend: --
Yield (%): --

Financials

  NBY.A Industry Sector
P/E (TTM): -- 137.42 33.38
EPS (TTM): -0.34 -- --
ROI: -134.60 -1.55 17.53
ROE: -176.41 -6.69 18.34
Search Stocks

Competitors

  Price Change
PuriCore plc (PURI.L) 34.00p 0.00
C.R. Bard, Inc. (BCR.N) $149.22 +2.50
Smith & Nephew plc (SN.L) 962.00p +16.50
Abbott Laboratories (ABT.N) $42.39 +0.93
GlaxoSmithKline plc (GSK.L) 1,342.00p +3.00
3M Co (MMM.N) $140.93 +3.33
Sanofi SA (SASY.PA) €81.48 +1.05
Pfizer Inc. (PFE.N) $28.28 +0.35
Novartis AG (NOVN.VX) CHF83.55 +0.75
Johnson & Johnson (JNJ.N) $100.36 +1.16

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks